ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Investment

DWK expands glass vial production

by Craig Bettenhausen
September 4, 2020 | APPEARED IN VOLUME 98, ISSUE 34

 

09834-buscon8-robot.jpg
Credit: DWK/Business Wire
A robot arm involved in making DWK's borosilicate glass vials

Vaccines for COVID-19 won’t do much good if drug firms don’t have vials to put them in. The lab and medical glass firm DWK Life Sciences has expanded its plant in Tennessee to help meet the anticipated demand. The firm says it has upgraded production lines and added new, fully automated ones, more than doubling the output of borosilicate glass vials. The US government also expects a rush on vials. It recently funded capacity upgrades at Corning and SiO2 Materials Sciences.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment